Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.
Ünal Ç, Azizy A, Karabulut S, Taştekin D, Akyıldız A, Yaşar S, Yalçın Ş, Çoban E, Evrensel T, Kalkan Z, Oruç Z, Derin S, Turna ZH, Bayram D, Köş FT, Şendur MAN, Sever N, Ercelep Ö, Seyyar M, Kefeli U, Uygun K, Özçelik M, Ön S, Şanlı UA, Canaslan K, Ünek İT, Yücel KB, Özdemir N, Yazıcı O, Güzel HG, Salim DK, Göksu SS, Tatlı AM, Ordu Ç, Selvi O, Sakin A, Büyükbayram ME, Dursun B, Ürün Y, Arak H, Ağdaş G, Uğraklı M, Hendem E, Eryılmaz MK, Bilgin B, Topçu A, Şimşek M, Büyükşimşek M, Akay B, Erdal GŞ, Karataş F, Alan Ö, Çağlayan M, Kahvecioğlu FA, Demirci A, Paksoy N, Çetin B, Gümüş M, Ak N, Aydınalp Y, Paydaş S, Güven DC, Kılıçkap S, Sağlam S. Ünal Ç, et al. Among authors: yucel kb. Oncologist. 2023 Oct 3;28(10):875-884. doi: 10.1093/oncolo/oyad257. Oncologist. 2023. PMID: 37676712 Free PMC article.
ROAR trial: which treatment is effective after progression?
Sütcüoğlu O, Yücel KB, Üner A, Yazici O, Özdemir N. Sütcüoğlu O, et al. Among authors: yucel kb. Lancet Oncol. 2022 Mar;23(3):e93. doi: 10.1016/S1470-2045(21)00754-3. Lancet Oncol. 2022. PMID: 35240094 No abstract available.
The relationship between systemic immune inflammation index and survival in patients with metastatic renal cell carcinomatreated withtyrosine kinase inhibitors.
Yücel KB, Yekedüz E, Karakaya S, Tural D, Ertürk İ, Erol C, Ercelep Ö, Öztaş NŞ, Arslan Ç, Uçar G, Küçükarda A, Sever ÖN, Kılıçkap S, Can O, Yazgan SC, Öksüzoğlu B, Karadurmuş N, Şendur MA, Ürün Y. Yücel KB, et al. Sci Rep. 2022 Oct 3;12(1):16559. doi: 10.1038/s41598-022-20056-3. Sci Rep. 2022. PMID: 36192500 Free PMC article.
Effect of HER2/CEP17 ratio on survival in metastatic HER2-positive gastric cancer, multicenter study.
Sekmek S, Karahan I, Ucar G, Ceylan F, Bayram D, Seven I, Bölek H, Ürün Y, Yücel KB, Yazici O, Kadioglu A, Karacin C, Canaslan K, Atag E, Demirer S, Erdem GU, Ergun Y, Atak M, Koksal B, Kiran MM, Turkay DO, Civelek B, Yalcin B, Uncu D. Sekmek S, et al. Among authors: yucel kb. Clin Transl Oncol. 2024 Mar 7. doi: 10.1007/s12094-024-03410-x. Online ahead of print. Clin Transl Oncol. 2024. PMID: 38451412